John Vernachio

1.4k total citations
23 papers, 958 citations indexed

About

John Vernachio is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, John Vernachio has authored 23 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 13 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in John Vernachio's work include Antimicrobial Resistance in Staphylococcus (9 papers), Biochemical and Structural Characterization (4 papers) and Streptococcal Infections and Treatments (4 papers). John Vernachio is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (9 papers), Biochemical and Structural Characterization (4 papers) and Streptococcal Infections and Treatments (4 papers). John Vernachio collaborates with scholars based in United States, United Kingdom and Belgium. John Vernachio's co-authors include Joseph M. Patti, Peter J. Syribeys, Elena Gorovits, Jeff Hutchins, Mark J. Soloski, Andrea Hall, Brenda Ames, Paul Domanski, Arnold S. Bayer and Bradley D. Prater and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

John Vernachio

22 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Vernachio United States	17	575	502	208	201	138	23	958
Claire Jones United Kingdom	20	334 0.6×	465 0.9×	605 2.9×	174 0.9×	59 0.4×	36	1.3k
Lisa A. Purcell United States	14	736 1.3×	317 0.6×	221 1.1×	218 1.1×	293 2.1×	26	1.4k
Donald H. Rubin United States	19	666 1.2×	348 0.7×	431 2.1×	269 1.3×	84 0.6×	37	1.4k
Rienk E. Jeeninga Netherlands	22	569 1.0×	695 1.4×	307 1.5×	437 2.2×	57 0.4×	45	1.6k
Andrés H. Gutiérrez United States	20	264 0.5×	622 1.2×	343 1.6×	305 1.5×	131 0.9×	49	1.1k
Masashi Tatsumi Japan	18	474 0.8×	335 0.7×	258 1.2×	148 0.7×	74 0.5×	63	1.1k
Hidehito Kato Japan	22	509 0.9×	295 0.6×	555 2.7×	184 0.9×	249 1.8×	50	1.3k
Ruizhong Shen United States	18	317 0.6×	291 0.6×	500 2.4×	217 1.1×	28 0.2×	28	1.2k
Michael W. Cho United States	19	815 1.4×	421 0.8×	715 3.4×	355 1.8×	62 0.4×	36	1.8k
Jason B. Dinoso United States	15	776 1.3×	208 0.4×	288 1.4×	160 0.8×	78 0.6×	21	1.2k

Countries citing papers authored by John Vernachio

Since Specialization

Citations

This map shows the geographic impact of John Vernachio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Vernachio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Vernachio more than expected).

Fields of papers citing papers by John Vernachio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Vernachio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Vernachio. The network helps show where John Vernachio may publish in the future.

Co-authorship network of co-authors of John Vernachio

This figure shows the co-authorship network connecting the top 25 collaborators of John Vernachio. A scholar is included among the top collaborators of John Vernachio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Vernachio. John Vernachio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cox, Robert M., Märt Toots, Jeong-Joong Yoon, et al.. (2018). Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex. Journal of Biological Chemistry. 293(43). 16761–16777. 25 indexed citations

Sun, Liang, Adam Meijer, Matheus Froeyen, et al.. (2015). Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68. Antimicrobial Agents and Chemotherapy. 59(12). 7782–7785. 55 indexed citations

McGuigan, Christopher, Marco Derudas, Nadège Hamon, et al.. (2013). Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides. European Journal of Medicinal Chemistry. 70. 326–340. 25 indexed citations

Hawkins, Julio C., Srinivas Kodali, Yury V. Matsuka, et al.. (2012). A Recombinant Clumping Factor A-Containing Vaccine Induces Functional Antibodies to Staphylococcus aureus That Are Not Observed after Natural Exposure. Clinical and Vaccine Immunology. 19(10). 1641–1650. 55 indexed citations

McGuigan, Christopher, Karolina Madela, Arnaud Gilles, et al.. (2011). Dual pro-drugs of 2′-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 21(19). 6007–6012. 14 indexed citations

Hutchins, Jeff, Christopher McGuigan, Stanley D. Chamberlain, et al.. (2011). DMPK and Metabolism Studies of Nucleoside Phosphoramidates Including INX-08189, A Novel Double Pro-drug and Clinical Candidate for Hepatitis C Virus Therapy. Antiviral Research. 90(2). A22–A23. 1 indexed citations

McGuigan, Christopher, Karolina Madela, Arnaud Gilles, et al.. (2010). Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 20(16). 4850–4854. 73 indexed citations

Coleman, D. A., Soon-Hwan Oh, Xiaomin Zhao, et al.. (2009). Monoclonal antibodies specific for Candida albicans Als3 that immunolabel fungal cells in vitro and in vivo and block adhesion to host surfaces. Journal of Microbiological Methods. 78(1). 71–78. 57 indexed citations

Hall, Andrea, Pratiksha Patel, Paul Domanski, et al.. (2007). A Panel of Monoclonal Antibodies Recognizing the Staphylococcus epidermidis Fibrinogen-Binding MSCRAMM SdrG. Hybridoma. 26(1). 28–34. 5 indexed citations

10.

Hall, Andrea, Elena Gorovits, Peter J. Syribeys, et al.. (2007). Monoclonal antibodies recognizing the Enterococcus faecalis collagen-binding MSCRAMM Ace: Conditional expression and binding analysis. Microbial Pathogenesis. 43(2-3). 55–66. 22 indexed citations

11.

Vernachio, John, Arnold S. Bayer, Brenda Ames, et al.. (2006). Human Immunoglobulin G Recognizing Fibrinogen-Binding Surface Proteins Is Protective against both Staphylococcus aureus and Staphylococcus epidermidis Infections In Vivo. Antimicrobial Agents and Chemotherapy. 50(2). 511–518. 55 indexed citations

12.

Domanski, Paul, Pratiksha Patel, Arnold S. Bayer, et al.. (2005). Characterization of a Humanized Monoclonal Antibody Recognizing Clumping Factor A Expressed by Staphylococcus aureus. Infection and Immunity. 73(8). 5229–5232. 59 indexed citations

13.

Höök, Magnus, David L. Haviland, Rick A. Wetsel, et al.. (2004). Inhibition of Complement Activation by a SecretedStaphylococcus aureusProtein. The Journal of Infectious Diseases. 190(3). 571–579. 104 indexed citations

14.

Hall, Andrea, Paul Domanski, Pratiksha Patel, et al.. (2003). Characterization of a Protective Monoclonal AntibodyRecognizing Staphylococcus aureus MSCRAMM ProteinClumping FactorA. Infection and Immunity. 71(12). 6864–6870. 112 indexed citations

15.

Vernachio, John, Arnold S. Bayer, Thuan Le, et al.. (2003). Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective Endocarditis. Antimicrobial Agents and Chemotherapy. 47(11). 3400–3406. 81 indexed citations

16.

Fairman, Jeff, Edward Fox, Gary S. Koe, et al.. (1999). Quantitative RT-PCR to Evaluate In Vivo Expression of Multiple Transgenes Using a Common Intron. BioTechniques. 27(3). 566–574. 16 indexed citations

17.

Smith, Janet G., et al.. (1998). Characterization and In Vivo Testing of a Heterogeneous Cationic Lipid-DNA Formulation. Pharmaceutical Research. 15(9). 1356–1363. 29 indexed citations

18.

Servenius, B, John Vernachio, Jennifer L. Price, Leif C. Andersson, & Per A. Peterson. (1994). Metastasizing neuroblastomas in mice transgenic for simian virus 40 large T (SV40T) under the olfactory marker protein gene promoter.. PubMed. 54(19). 5198–205. 17 indexed citations

19.

Conrad, Daniel H., et al.. (1993). Chromosomal location and isoform analysis of mouse Fcϵ RII/CD23. Molecular Immunology. 30(1). 27–33. 16 indexed citations

20.

Vernachio, John, Ming‐Qing Li, Albert D. Donnenberg, & Mark J. Soloski. (1989). Qa-2 expression in the adult murine thymus. A unique marker for a mature thymic subset.. The Journal of Immunology. 142(1). 48–56. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact